Many are cured: Lymphoblastic lymphoma (LBL) and Burkitt lymphoma (BL) are both aggressive lymphomas with a rapid rate of cell division. For patients who are able to receive intensive chemotherapy regimens and rituximab antibody, recent trials have reported sustained disease-free survival in 60-90% of patients.
Answered 1/3/2015
3.4k views
3 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question